UBS AM’s Blueprint Medicines BPMC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $27.7M | Sell |
215,946
-28,465
| -12% | -$3.65M | 0.01% | 914 |
|
|
2025
Q1 | $21.6M | Buy |
244,411
+4,465
| +2% | +$395K | 0.01% | 929 |
|
|
2024
Q4 | $20.9M | Buy |
239,946
+12,035
| +5% | +$1.05M | ﹤0.01% | 925 |
|
|
2024
Q3 | $21.1M | Sell |
227,911
-73,962
| -25% | -$6.84M | 0.01% | 926 |
|
|
2024
Q2 | $32.5M | Buy |
301,873
+67,258
| +29% | +$7.25M | 0.01% | 720 |
|
|
2024
Q1 | $22.3M | Sell |
234,615
-4,558
| -2% | -$432K | 0.01% | 762 |
|
|
2023
Q4 | $22.1M | Sell |
239,173
-3,019
| -1% | -$278K | 0.01% | 746 |
|
|
2023
Q3 | $12.2M | Sell |
242,192
-10,157
| -4% | -$510K | 0.01% | 890 |
|
|
2023
Q2 | $11.4M | Hold |
252,349
| – | – | 0.01% | 922 |
|
|
2023
Q1 | $11.4M | Sell |
252,349
-9,336
| -4% | -$420K | 0.01% | 922 |
|
|
2022
Q4 | $11.5M | Sell |
261,685
-6,790
| -3% | -$297K | 0.01% | 893 |
|
|
2022
Q3 | $17.7M | Sell |
268,475
-11,887
| -4% | -$783K | 0.01% | 791 |
|
|
2022
Q2 | $14.2M | Buy |
280,362
+40,386
| +17% | +$2.04M | 0.01% | 838 |
|
|
2022
Q1 | $15.3M | Buy |
239,976
+5,369
| +2% | +$343K | 0.01% | 921 |
|
|
2021
Q4 | $25.1M | Sell |
234,607
-26,474
| -10% | -$2.84M | 0.01% | 844 |
|
|
2021
Q3 | $26.8M | Sell |
261,081
-21,288
| -8% | -$2.19M | 0.01% | 793 |
|
|
2021
Q2 | $24.8M | Buy |
282,369
+24,204
| +9% | +$2.13M | 0.01% | 833 |
|
|
2021
Q1 | $25.1M | Sell |
258,165
-79,837
| -24% | -$7.76M | 0.01% | 806 |
|
|
2020
Q4 | $37.9M | Buy |
338,002
+37,040
| +12% | +$4.15M | 0.02% | 676 |
|
|
2020
Q3 | $27.9M | Buy |
300,962
+21,750
| +8% | +$2.02M | 0.02% | 679 |
|
|
2020
Q2 | $21.8M | Buy |
279,212
+187,039
| +203% | +$14.6M | 0.01% | 717 |
|
|
2020
Q1 | $5.39M | Sell |
92,173
-45,679
| -33% | -$2.67M | ﹤0.01% | 1028 |
|
|
2019
Q4 | $11M | Buy |
137,852
+1,910
| +1% | +$153K | 0.01% | 910 |
|
|
2019
Q3 | $9.99M | Buy |
135,942
+3,834
| +3% | +$282K | 0.01% | 959 |
|
|
2019
Q2 | $12.5M | Buy |
132,108
+1,953
| +2% | +$184K | 0.01% | 892 |
|
|
2019
Q1 | $10.4M | Buy |
130,155
+4,419
| +4% | +$354K | 0.01% | 925 |
|
|
2018
Q4 | $6.78M | Sell |
125,736
-7,883
| -6% | -$425K | 0.01% | 975 |
|
|
2018
Q3 | $10.4M | Buy |
133,619
+6,739
| +5% | +$526K | 0.01% | 924 |
|
|
2018
Q2 | $8.05M | Buy |
126,880
+18,876
| +17% | +$1.2M | 0.01% | 996 |
|
|
2018
Q1 | $9.9M | Sell |
108,004
-1,784
| -2% | -$164K | 0.01% | 932 |
|
|
2017
Q4 | $8.28M | Buy |
109,788
+1,125
| +1% | +$84.8K | 0.01% | 964 |
|
|
2017
Q3 | $7.57M | Buy |
108,663
+95,612
| +733% | +$6.66M | 0.01% | 968 |
|
|
2017
Q2 | $661K | Buy |
13,051
+8,036
| +160% | +$407K | ﹤0.01% | 1800 |
|
|
2017
Q1 | $201K | Buy |
+5,015
| New | +$201K | ﹤0.01% | 2192 |
|
|
2016
Q4 | – | Sell |
-11,015
| Closed | -$327K | – | 2521 |
|
|
2016
Q3 | $327K | Buy |
11,015
+915
| +9% | +$27.2K | ﹤0.01% | 2218 |
|
|
2016
Q2 | $205K | Hold |
10,100
| – | – | ﹤0.01% | 2433 |
|
|
2016
Q1 | $182K | Sell |
10,100
-114,331
| -92% | -$2.06M | ﹤0.01% | 2457 |
|
|
2015
Q4 | $3.28M | Sell |
124,431
-10,490
| -8% | -$276K | ﹤0.01% | 1220 |
|
|
2015
Q3 | $2.88M | Buy |
134,921
+15,642
| +13% | +$334K | ﹤0.01% | 1262 |
|
|
2015
Q2 | $3.16M | Buy |
+119,279
| New | +$3.16M | ﹤0.01% | 1207 |
|